
Tris Pharma, a New Jersey-based medical organization, innovates drug delivery technologies and medicines for disease treatment.
Founded in Monmouth Junction, New Jersey, Tris Pharma is dedicated to innovating drug delivery technologies and developing medicines for disease treatment. The company's core mission is to enhance patient outcomes through advanced pharmaceutical solutions. Tris Pharma's product portfolio includes treatments for ADHD, pain management, and other central nervous system (CNS) disorders, focusing primarily on the U.S. market.
Notable figures affiliated with Tris Pharma include its leadership team and scientific advisors who bring extensive expertise in pharmaceuticals. The company has achieved significant milestones in drug development and delivery technology, contributing to improved therapeutic options for patients. Tris Pharma's impact is evident in its commitment to innovation and patient care, positioning it as a key player in the pharmaceutical industry.

Trilogic Pharma
trilogicpharma.com

Trevena

Trigemina

Trim-Edicine
trim-edicine.com

Pharmos
pharmoscorp.com

Tigris Pharmaceuticals
tigrispharma.com
Assertio Holdings

Novartis Pharma

Supernus Pharmaceuticals
supernus.com

Viatris
viatris.com

Truveris
truveris.com

Collegium Pharmaceutical

Acadia Pharmaceuticals
acadia-pharm.com

6S Pharma
6spharma.com

Aquestive Therapeutics
aquestive.com
Companies similar to Tris Pharma include Trilogic Pharma, Trevena, Trigemina and Trim-Edicine.
Tris Pharma was founded in 2000.
Tris Pharma's headquarters is located in Monmouth Junction, NJ, US.
Tris Pharma's most recent funding round was for $16.6M (USD) in August 2023.
As of Aug 28, 2023, Tris Pharma has raised a total of $141.6M (USD).
Tris Pharma has 350 employees as of Feb 4, 2024.